4//SEC Filing
Zweiman Ari 4
Accession 0001567619-19-018586
CIK 0001130598other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 3:21 PM ET
Size
16.0 KB
Accession
0001567619-19-018586
Insider Transaction Report
Form 4
Zweiman Ari
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2019-09-18$2.18/sh−173,332$377,448→ 581,533 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.18/sh−118,726$258,538→ 848,151 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.20/sh−1,533$3,376→ 460,000 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$1.86/sh−93,286$173,139→ 754,865 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$1.82/sh−120,000$218,184→ 461,533 total(indirect: By 683 Capital Partners, LP)
683 Capital Management, LLC
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2019-09-18$1.86/sh−93,286$173,139→ 754,865 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.18/sh−173,332$377,448→ 581,533 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$1.82/sh−120,000$218,184→ 461,533 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.18/sh−118,726$258,538→ 848,151 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.20/sh−1,533$3,376→ 460,000 total(indirect: By 683 Capital Partners, LP)
683 Capital Partners, LP
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2019-09-18$1.86/sh−93,286$173,139→ 754,865 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$1.82/sh−120,000$218,184→ 461,533 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.18/sh−118,726$258,538→ 848,151 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.18/sh−173,332$377,448→ 581,533 total(indirect: By 683 Capital Partners, LP) - Sale
Common Stock, $0.01 par value
2019-09-18$2.20/sh−1,533$3,376→ 460,000 total(indirect: By 683 Capital Partners, LP)
Footnotes (2)
- [F1]This Form 4 is filed jointly by 683 Capital Management, LLC ("683 Management"), 683 Capital Partners, LP ("683 Partners") and Ari Zweiman (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that no longer collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- [F2]Represents securities held directly by 683 Partners. 683 Management is the investment manager of 683 Partners. Ari Zweiman is the Managing Member of 683 Management. As a result, each of 683 Management and Ari Zweiman may be deemed to beneficially own the securities held by 683 Partners.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001612431
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 3:21 PM ET
- Size
- 16.0 KB